Tech Company Financing Transactions
Moderna Funding Round
Biomedical Advanced Research and Development Authority joined a $590 million funding round for Moderna. The round was announced on 1/20/2025.
Transaction Overview
Company Name
Announced On
1/20/2025
Transaction Type
Venture Equity
Amount
$590,000,000
Round
Undisclosed
Proceeds Purpose
Moderna intends to use the above-mentioned funds to support the late-stage development of mRNA-1018, its investigational pandemic influenza vaccine against H5 and H7 avian influenza viruses. Per management, the funding will also help fund the expansion of clinical studies for up to five additional pandemic influenza subtypes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Technology Sq.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
At Moderna (Nasdaq: MRNA), we are pioneering the development of a new class of drugs made of messenger RNA (mRNA).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stéphane Bancel
Chief Medical Officer
Tal Zaks
President
Stephen Hoge
VP - General Counsel
Lori Henderson
VP - Manufacturing
Juan Andres
Browse more venture capital transactions:
Prev: 1/20/2025: ecoplanet venture capital transaction
Next: 1/20/2025: alteva venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs